Skip to main content
Top
Gepubliceerd in: Quality of Life Research 11/2015

23-05-2015

Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study

Auteur: Boon-How Chew

Gepubliceerd in: Quality of Life Research | Uitgave 11/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This study examined the association between medication adherence (MA) and health-related quality of life (HRQoL) among the adult type 2 diabetes mellitus at the primary care level.

Methods

In this cross-sectional study, the 8-item Morisky Medication Adherence Scale (MMAS) was the main independent variable and the World Health Organization Quality of Life-Brief the dependent variable. Besides socio-demographic data, diabetes-related distress (DRD) and depression (DS) were included as covariates. Independent association between the MMAS score and HRQoL was done using multiple linear regression.

Results

The participants’ response rate was 93.1 % (700/752). Majorities were female (52.8 %), Malay (52.9 %) and married (79.1 %). The mean (SD) for age and the MMAS score was 56.9 (10.18) and 5.6 (1.42), respectively. MMAS total score correlated significantly with all HRQoL domains: overall QoL (OQoL) (r = 0.17), physical QoL (r = 0.11), psychological QoL (r = 0.10), social relationship QoL (r = 0.15) and environmental QoL (EQoL) (r = 0.18). After adjustment for covariates (age, gender, ethnicity, religion, education, income, exercise, macrovascular complications, DRD and DS), MA had persistent effects on OQoL (B = 0.53, 95 % CI 0.012–1.048) and EQoL (B = 0.95, 95 % CI 0.235–1.667).

Conclusion

MA showed prevalent correlation and positive effects on the domains of HRQoL. Despite the small effects of MA on HRQoL, the sheer presence of the independent effects provides healthcare providers good reason for initiative and intervention to improve MA, which would improve quality of life.
Literatuur
1.
go back to reference Asche, C., LaFleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33, 74–109.CrossRefPubMed Asche, C., LaFleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33, 74–109.CrossRefPubMed
2.
go back to reference Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.CrossRefPubMed Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.CrossRefPubMed
3.
go back to reference Manan, M. M., Husin, A. R., Alkhoshaiban, A. S., Al-Worafi, Y. M., & Ming, L. C. (2014). Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. Journal of Clinical and Diagnostic Research, 8, JC05–JC09.PubMedCentralPubMed Manan, M. M., Husin, A. R., Alkhoshaiban, A. S., Al-Worafi, Y. M., & Ming, L. C. (2014). Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. Journal of Clinical and Diagnostic Research, 8, JC05–JC09.PubMedCentralPubMed
4.
go back to reference Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42, 102–109.CrossRefPubMed Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42, 102–109.CrossRefPubMed
5.
go back to reference Martinez, Y. V., Prado-Aguilar, C. A., Rascon-Pacheco, R. A., & Valdivia-Martinez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8, 164.PubMedCentralCrossRefPubMed Martinez, Y. V., Prado-Aguilar, C. A., Rascon-Pacheco, R. A., & Valdivia-Martinez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8, 164.PubMedCentralCrossRefPubMed
6.
go back to reference Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348–354.PubMedCentralCrossRefPubMed Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348–354.PubMedCentralCrossRefPubMed
7.
go back to reference Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90, 216–221.PubMedCentralCrossRefPubMed Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90, 216–221.PubMedCentralCrossRefPubMed
8.
go back to reference Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.CrossRefPubMed Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.CrossRefPubMed
9.
go back to reference Group, T.W. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28, 551–558.CrossRef Group, T.W. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28, 551–558.CrossRef
10.
go back to reference Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care, 28, 626–631.CrossRefPubMed Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care, 28, 626–631.CrossRefPubMed
11.
go back to reference El Achhab, Y., Nejjari, C., Chikri, M., & Lyoussi, B. (2008). Disease-specific health-related quality of life instruments among adults diabetic: A systematic review. Diabetes Research and Clinical Practice, 80, 171–184.CrossRefPubMed El Achhab, Y., Nejjari, C., Chikri, M., & Lyoussi, B. (2008). Disease-specific health-related quality of life instruments among adults diabetic: A systematic review. Diabetes Research and Clinical Practice, 80, 171–184.CrossRefPubMed
12.
go back to reference Fisher, L., Hessler, D. M., Polonsky, W. H., & Mullan, J. (2012). When is diabetes distress clinically meaningful?: Establishing cut points for the Diabetes Distress Scale. Diabetes Care, 35, 259–264.PubMedCentralCrossRefPubMed Fisher, L., Hessler, D. M., Polonsky, W. H., & Mullan, J. (2012). When is diabetes distress clinically meaningful?: Establishing cut points for the Diabetes Distress Scale. Diabetes Care, 35, 259–264.PubMedCentralCrossRefPubMed
13.
go back to reference Chew, B. H., Mukhtar, F., Mohd-Sidik, S., Paimin, F., Noor-Hasliza Hassan, N.-H., Jamaludin, N.-K. (2015). The 17-items Diabetes Distress Scale (DDS): Translation and validation of the Malay version. Malays Fam Physician (submitted). Chew, B. H., Mukhtar, F., Mohd-Sidik, S., Paimin, F., Noor-Hasliza Hassan, N.-H., Jamaludin, N.-K. (2015). The 17-items Diabetes Distress Scale (DDS): Translation and validation of the Malay version. Malays Fam Physician (submitted).
14.
go back to reference Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613.PubMedCentralCrossRefPubMed Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613.PubMedCentralCrossRefPubMed
15.
go back to reference Sherina, M. S., Arroll, B., & Goodyear-Smith, F. (2012). Criterion validity of the PHQ-9 (Malay version) in a primary care clinic in Malaysia. Medical Journal of Malaysia, 67, 309–315.PubMed Sherina, M. S., Arroll, B., & Goodyear-Smith, F. (2012). Criterion validity of the PHQ-9 (Malay version) in a primary care clinic in Malaysia. Medical Journal of Malaysia, 67, 309–315.PubMed
16.
go back to reference WHO Consultation. (1999. Report no. 99.2.). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization. WHO Consultation. (1999. Report no. 99.2.). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization.
17.
go back to reference Ministry of Health, Malaysia. (2009). Management of type 2 diabetes mellitus. Putrajaya: Technology, Health Section, Assessment Division, Medical Development. Ministry of Health, Malaysia. (2009). Management of type 2 diabetes mellitus. Putrajaya: Technology, Health Section, Assessment Division, Medical Development.
18.
go back to reference American Diabetes Association. (2015). Standards of medical care in diabetes—2015. Diabetes Care, 38, S1–S93. American Diabetes Association. (2015). Standards of medical care in diabetes—2015. Diabetes Care, 38, S1–S93.
19.
go back to reference Fisher, L., Mullan, J. T., Arean, P., Glasgow, R. E., Hessler, D., & Masharani, U. (2010). Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care, 33, 23–28.PubMedCentralCrossRefPubMed Fisher, L., Mullan, J. T., Arean, P., Glasgow, R. E., Hessler, D., & Masharani, U. (2010). Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care, 33, 23–28.PubMedCentralCrossRefPubMed
20.
go back to reference van Bastelaar, K. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Tack, C. J., Bazelmans, E., Beekman, A. T., et al. (2010). Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabetic Medicine, 27, 798–803.CrossRefPubMed van Bastelaar, K. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Tack, C. J., Bazelmans, E., Beekman, A. T., et al. (2010). Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabetic Medicine, 27, 798–803.CrossRefPubMed
21.
go back to reference Ahmad, N. S., Ramli, A., Islahudin, F., & Paraidathathu, T. (2013). Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference Adherence, 7, 525–530.PubMedCentralPubMed Ahmad, N. S., Ramli, A., Islahudin, F., & Paraidathathu, T. (2013). Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference Adherence, 7, 525–530.PubMedCentralPubMed
22.
go back to reference (2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. In NICE clinical guideline 76. Manchester, UK. (2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. In NICE clinical guideline 76. Manchester, UK.
23.
go back to reference Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., & Lindenmeyer, A. (2005). Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online), CD003638–CD003638. Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., & Lindenmeyer, A. (2005). Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online), CD003638–CD003638.
24.
go back to reference Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65, 314–322.CrossRefPubMed Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65, 314–322.CrossRefPubMed
25.
go back to reference Non-Communicable Disease Section, Disease Control Division, Department of Public Health. National Diabetes Registry Report, Volume 1: 2009–2012 (2013). Non-Communicable Disease Section, Disease Control Division, Department of Public Health. National Diabetes Registry Report, Volume 1: 20092012 (2013).
Metagegevens
Titel
Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study
Auteur
Boon-How Chew
Publicatiedatum
23-05-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 11/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1006-7

Andere artikelen Uitgave 11/2015

Quality of Life Research 11/2015 Naar de uitgave